首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)

Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)

产品编号

YR1285

别名

科研级 Ocaratuzumab ( 奥卡妥珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Ocaratuzumab ( 奥卡妥珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab
Catalog NumberYR1285
Molecular NameOcaratuzumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundOcaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes.
CAS Number1169956-08-4
ApplicationNeut, ELISA, IF, IP, FuncS, FCM, ICC
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD20[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价